3804 people with COVID-19 hospitalized in Russia per day

This was reported in the operational headquarters for the fight against COVID-19.

As previously reported by the director of the center.

Gamalei Alexander Gintsburg, a drug for coronavirus based on monoclonal antibodies, which is being developed at the center, is planned to be used on the third or fourth day after a patient with COVID-19 is admitted to the hospital.

Doctor of Biological Sciences, Professor of the Department of Virology at the Faculty of Biology of Moscow State University Alexei Agranovsky, in an interview with NSN, spoke about immunity in those who had been ill with Omicron.